(Q40642626)

English

ACE inhibition and cardiovascular mortality and morbidity in essential hypertension: the end of the search or a need for further investigations?

scientific article published on April 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

ACE inhibition and cardiovascular mortality and morbidity in essential hypertension: the end of the search or a need for further investigations? (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Luis Miguel Ruilope

object named as

Luis M Ruilope

1

0 references

author name string

Antonio Coca

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Bernard Waeber

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

4 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

367-371

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Laragh's lessons in pathophysiology and clinical pearls for treating hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Laragh's lessons in pathophysiology and clinical pearls for treating hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Laragh's lessons in pathophysiology and clinical pearls for treating hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

DuP 753 Increases Survival in Spontaneously Hypertensive Stroke-Prone Rats Fed a High Sodium Diet

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure control, proteinuria and renal outcome in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Case-control study of stroke and the quality of hypertension control in north west England

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular protection and blood pressure reduction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902258-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0895-7061(02)02258-6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40642626&oldid=1504001009"